Back to Search
Start Over
Optical control of the β 2 -adrenergic receptor with opto-prop-2: A cis -active azobenzene analog of propranolol.
- Source :
-
IScience [iScience] 2022 Aug 05; Vol. 25 (9), pp. 104882. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- In this study, we synthesized and evaluated new photoswitchable ligands for the beta-adrenergic receptors β <subscript>1</subscript> -AR and β <subscript>2</subscript> -AR, applying an azologization strategy to the first-generation beta-blocker propranolol. The resulting compounds (Opto-prop-1, -2, -3) have good photochemical properties with high levels of light-induced trans - cis isomerization (>94%) and good thermal stability ( t <subscript>1/2</subscript>  > 10 days) of the resulting cis -isomer in an aqueous buffer. Upon illumination with 360-nm light to PSS <subscript> cis </subscript> , large differences in binding affinities were observed for photoswitchable compounds at β <subscript>1</subscript> -AR as well as β <subscript>2</subscript> -AR. Notably, Opto-prop-2 (VUF17062) showed one of the largest optical shifts in binding affinities at the β <subscript>2</subscript> -AR (587-fold, cis -active), as recorded so far for photoswitches of G protein-coupled receptors. We finally show the broad utility of Opto-prop-2 as a light-dependent competitive antagonist of the β <subscript>2</subscript> -AR as shown with a conformational β <subscript>2</subscript> -AR sensor, by the recruitment of downstream effector proteins and functional modulation of isolated adult rat cardiomyocytes.<br />Competing Interests: The authors declare no competing interests.<br /> (© 2022 The Author(s).)
Details
- Language :
- English
- ISSN :
- 2589-0042
- Volume :
- 25
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- IScience
- Publication Type :
- Academic Journal
- Accession number :
- 36060054
- Full Text :
- https://doi.org/10.1016/j.isci.2022.104882